Amarin Corporation PLC at Goldman Sachs Healthcare Conference Transcript
Okay. We'll continue with our next session. I'm Paul Choi, and I cover the small and mid-cap biotechnology sector here at Goldman Sachs. Our next session is with Amarin and we're joined by 2 members of the management team. To my immediate left is the CEO, Aaron Berg, and to my follow-up, CFO, Tom Reilly. What we'll do is Q&A as we have in prior sessions. If there are questions along the way from the audience, please feel free to raise your hand and we can get a mic to you. Alternatively, if you want to ask a question anonymously, please feel free to send me an e-mail and I'll read the question out loud over the Internet for anybody who may have questions online.
Questions & Answers
So maybe with that, I'll start with you, Aaron and then maybe you've been in the seat for a few weeks now and maybe high-level impressions as you've been in the job here and just kind of like how you're thinking about your
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
